Literature DB >> 10446458

Ethanol decreases host resistance to pulmonary metastases in a mouse model: role of natural killer cells and the ethanol-induced stress response.

W J Wu1, S B Pruett.   

Abstract

The present study was done to delineate cause-effect relationships between the ethanol (EtOH)-induced stress response, natural-killer (NK)-cell activity, and resistance to experimental metastases of B16F10 melanoma cells in mice. Increased numbers of metastatic nodules were noted in the lungs of mice treated with dosages of EtOH that produce peak blood levels of 0.25-0.4%. EtOH caused only a minor depletion of NK cells or NK-cell activity from the spleen or lungs of normal or B16F10-challenged mice. However, in earlier studies we have shown consistent, significant decreases in NK-cell activity (approx. 50%) in spleen preparations from EtOH-treated mice. Depletion of NK cells by a monoclonal antibody increased the number of B16F10 nodules in the lungs, confirming an important role for NK cells for resistance to B16F10 metastases. Treatment of NK-cell-depleted mice with EtOH caused no further decrease in resistance to B16F10 cells, indicating that suppression of NK-cell activity is the major mechanism by which EtOH suppresses resistance to B16F10 metastases. Adrenalectomy or a glucocorticoid antagonist partially prevented EtOH-induced increases in the number of metastatic nodules in the lungs. Administration of exogenous corticosterone increased the number of B16F10 nodules to an extent similar to that caused by EtOH. These results indicate a role for the EtOH-induced stress response in decreasing resistance to B16F10 metastases. EtOH-induced decreases in resistance to cancer have also been reported in rats. The findings of the present study support the possibility that this is a generalized phenomenon, which could occur in humans. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10446458     DOI: 10.1002/(sici)1097-0215(19990909)82:6<886::aid-ijc19>3.0.co;2-j

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  8 in total

1.  Binge alcohol consumption 18 h after induction of sepsis in a mouse model causes rapid overgrowth of bacteria, a cytokine storm, and decreased survival.

Authors:  Minny Bhatty; Wei Tan; Maria Basco; Stephen Pruett; Bindu Nanduri
Journal:  Alcohol       Date:  2016-11-27       Impact factor: 2.405

Review 2.  Stimuli-induced organ-specific injury enhancement of organotropic metastasis in a spatiotemporal regulation.

Authors:  Dongwei Gao; Sha Li
Journal:  Pathol Oncol Res       Date:  2013-12-20       Impact factor: 3.201

3.  Dosage scaling of alcohol in binge exposure models in mice: An empirical assessment of the relationship between dose, alcohol exposure, and peak blood concentrations in humans and mice.

Authors:  Stephen Pruett; Wei Tan; George E Howell; Bindu Nanduri
Journal:  Alcohol       Date:  2020-04-04       Impact factor: 2.405

Review 4.  Exposure-dependent effects of ethanol on the innate immune system.

Authors:  Joanna Goral; John Karavitis; Elizabeth J Kovacs
Journal:  Alcohol       Date:  2008-04-14       Impact factor: 2.405

5.  Alcohol consumption suppresses mammary tumor metastasis in a syngeneic tumor transplantation model.

Authors:  Beth A Vorderstrasse; Tao Wang; Annette K Myers; Katherine L Wyrick; Gary G Meadows
Journal:  Breast Cancer Res Treat       Date:  2012-11-02       Impact factor: 4.872

6.  Inhalation of an ethanol-based zileuton formulation provides a reduction of pulmonary adenomas in the A/J mouse model.

Authors:  Kelly L Karlage; Erik Mogalian; Annikka Jensen; Paul B Myrdal
Journal:  AAPS PharmSciTech       Date:  2010-01-26       Impact factor: 3.246

Review 7.  Effects of Alcohol on Tumor Growth, Metastasis, Immune Response, and Host Survival.

Authors:  Gary G Meadows; Hui Zhang
Journal:  Alcohol Res       Date:  2015

Review 8.  Colorectal Cancer and Alcohol Consumption-Populations to Molecules.

Authors:  Marco Rossi; Muhammad Jahanzaib Anwar; Ahmad Usman; Ali Keshavarzian; Faraz Bishehsari
Journal:  Cancers (Basel)       Date:  2018-01-30       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.